Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study.
The OpenSAFELY Collaborative,; PARKER, EP K; TAZARE, J; Hulme, W; Bates, C; Beale, R; Carr, E; Cockburn, J; Curtis, H; Fisher, L; Green, AC A; Harper, S; Hester, F; Horne, EM F; Loud, F; Lyon, S; MAHALINGASIVAM, V; Mehrkar, A; Nab, L; Parry, J; Santhakumaran, S; Steenkamp, R; Sterne, JA C; Walker, A; Williamson, E; ... TOMLINSON, L.
2022
medRxiv (2022). 10.1101/2022.06.14.22276391.
Estimating the contribution of subclinical tuberculosis disease to transmission – an individual patient data analysis from prevalence surveys.
EMERY, J; Dodd, P; Banu, S; Frascella, B; Garden, F; HORTON, K; Hossain, S; Law, I; Van Leth, F; Marks, G; Nguyen, HB; Nguyen, HV; Onozaki, I; Quelapio, MI; RICHARDS, A; SHAIKH, N; Tiemersma, E; WHITE, R; Zaman, K; Cobelens, F; Houben, RM G J;
2022
medRxiv (2022). 10.1101/2022.06.09.22276188.
Vaccine equity in low and middle income countries: a systematic review and meta-analysis.
Ali, HA; Hartner, A-M; Echeverria-Londono, S; Roth, J; Li, X; ABBAS, K; Portnoy, A; VYNNYCKY, E; Woodruff, K; Ferguson, NM; Toor, J; Gaythorpe, KA;
2022
International Journal for Equity in Health, (2022).21 1 10.1186/s12939-022-01678-5.
Multiplex Serology for Measurement of IgG Antibodies Against Eleven Infectious Diseases in a National Serosurvey: Haiti 2014-2015.
Chan, Y; Martin, D; Mace, KE; Jean, SE; STRESMAN, G; DRAKELEY, C; Chang, MA; Lemoine, JF; Udhayakumar, V; Lammie, PJ; Priest, JW; Rogier, EW;
2022
Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.897013.
Non-COVID-19 vaccine hesitancy among migrant populations worldwide: a scoping review of the literature, 2000-2020.
Tankwanchi, AS; Jaca, A; Ndlambe, AM; Zantsi, ZP; Bowman, B; Garrison, MM; LARSON, HJ; Vermund, SH; Wiysonge, CS;
2022
Expert review of vaccines, (2022).21 9 10.1080/14760584.2022.2084075.
End-point definition and trial design to advance tuberculosis vaccine development.
Garcia-Basteiro, AL; WHITE, RG; Tait, D; Schmidt, AC; Rangaka, MX; Quaife, M; Nemes, E; Mogg, R; Hill, PC; Harris, RC; Hanekom, WA; Frick, M; Fiore-Gartland, A; Evans, T; Dagnew, AF; Churchyard, G; Cobelens, F; Behr, MA; Hatherill, M;
2022
European respiratory review, (2022).31 164 10.1183/16000617.0044-2022.
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP.
Hulme, W; WILLIAMSON, E; Horne, E; Green, A; Nab, L; KEOGH, R; PARKER, EP K; Walker, V; Palmer, T; Curtis, H; Wiedemann, M; Cunningham, C; Walker, A; Fisher, L; MacKenna, B; RENTSCH, C; SCHULTZE, A; BHASKARAN, K; TAZARE, J; TOMLINSON, L; MCDONALD, H; Morton, C; Croker, R; Andrews, C; Parks, R; ... GOLDACRE, B.
2022
medRxiv (2022). 10.1101/2022.06.06.22276026.
Immunogenicity and immunobridging of single dose HPV vaccine in Tanzanian girls – the DoRIS trial.
WATSON-JONES, D;
2022
(2022).
NK Cell Subset Redistribution and Antibody Dependent Activation after Ebola Vaccination in Africans.
Wagstaffe, HR; Anzala, O; Kibuuka, H; ANYWAINE, Z; Sirima, SB; Thiébaut, R; Richert, L; Levy, Y; Lacabaratz, C; Bockstal, V; Luhn, K; Douoguih, M; GOODIER, MR;
2022
Vaccines, (2022).10 6 10.3390/vaccines10060884.
COVID-19 impact on routine immunisations for vaccine-preventable diseases: Projecting the effect of different routes to recovery.
Toor, J; Li, X; JIT, M; Trotter, CL; Echeverria-Londono, S; Hartner, A-M; Roth, J; Portnoy, A; ABBAS, K; Ferguson, NM; Am Gaythorpe, K;
2022
Vaccine, (2022).40 31 10.1016/j.vaccine.2022.05.074.